Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Duchenne Muscular Dystrophy (DMD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Jiwen Wang) · wangjiwen@scmc.com.cn · 18916613192

Study leads

Jiwen Wang
Study Chair
Shanghai Children's Medical Center, affiliated to Shanghai Jiao Tong University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE1

Nashville, United States

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Little Rock, United States · Davis, United States

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Trial of Cell Based Therapy for DMD

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States